Basic Information
Basic information for SOX9-AS1-216-45aa
Peptide Name SOX9-AS1-216-45aa
Genome Position chr17:72040714-72040778,72081972-72082041[-]
Species Human
Peptide Sequence MSFGFWLSSLSGEPWQEAGKGEEGKNGATLGNPRAASRVNYTSNP
Peptide Length 45
Unique Yes
Grand Average of Hydropathicity -0.7756
Relative Molecular Mass 5579.91
Experimental Evidences 2:lncORF,ribo
lncRNA ID/Name ENSG00000234899;SOX9-AS1
Transcript ID/Name ENST00000602213;SOX9-AS1-216
Transcript Length 821
Coding Ability 0.3995
DNA Sequence Corresponding to Peptide ATGTCCTTTGGCTTCTGGTTGAGTTCACTCAGTGGAGAACCCTGGCAAGAGGCAGGAAAAGGGGAGGAAGGTAAAAATGGTGCTACCCTTGGAAATCCAAGAGCAGCTTCAAGAGTCAACTATACCAGCAATCCC
Experimental Evidences
   lncORF
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :